9 results
-
MSAC Consultation Survey - Application 1799
MSAC application 1799 - Transcatheter tricuspid valve replacement in patients with severe, symptomatic tricuspid regurgitation despite optimal medical therapy. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service... MoreCloses 10 October 2025 -
MSAC Consultation Survey - Application 1797
MSAC application 1797 - Vibration-Controlled Transient Elastography (VCTE™) for identifying advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a... MoreCloses 10 October 2025 -
MSAC Consultation Survey - Application 1798
MSAC application 1798 - Liquid biopsy genetic testing in patients with non-small cell lung cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses 10 October 2025 -
MSAC Consultation Survey - Application 1752
MSAC application 1752 - Anal human papillomavirus (HPV) and cytology testing in high-risk populations to determine access to high-resolution anoscopy and ablative treatment to prevent anal cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better... MoreCloses 10 October 2025 -
MSAC Consultation Survey - Application 1804
MSAC application 1804 - Genetic testing to detect RET variants in patients with medullary thyroid cancer to determine eligibility for PBS subsidised selpercatinib treatment. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed... MoreCloses today -
MSAC Consultation Survey - Application 1803
MSAC application 1803 - Implantation of an active middle ear implant (Vibroplasty) for treatment of mixed and conductive hearing loss. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... MoreCloses today -
MSAC Consultation Survey - Application 1802
MSAC application 1802 - Supervised oral food challenge (OFC) in patients with suspected food allergy. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses today -
MSAC Consultation Survey - Application 1805
MSAC application 1805 - Concizumab for routine prophylaxis to prevent bleeding in patients with haemophilia B. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses today -
MSAC Consultation Survey - Application 1806
MSAC application 1806 - Marstacimab for routine prophylaxis to prevent bleeding in patients with haemophilia. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses today
9 results.
Page 1 of 1